Skip to main navigation
Flexion

New paradigms for the treatment of pain

COVID-19 Update
  • Who We Are
    • Executive Committee
    • Board of Directors
    • Core Principles & Values
  • Our Product
  • Our Pipeline
  • Our Science
    • Unmet Need in Osteoarthritis
    • Clinical Trials and Associated Publications
  • News
    • Press Releases
  • Investors

    Investor Relations

    • Investors
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
      • Quarterly Results
      • Key Ratios
    • Stock Information
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings
    • Benefits and Incentives
    • Our Culture
  • Contact
    • Partnering
    • Medical Information Request Form
    • Investigator-Initiated Research
    • Medical Education/ Corporate Grants

Financials & Filings

Show all

2020

Fourth Quarter
  • Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 Results
  • Commercial Metrics Overview 359.8 KB

Annual Reports

Documents
  • Add Files
    2019 Annual Report 11.8 MB
  • Add Files
    2018 Annual Report 8.4 MB

Proxy Statements

Filing date View
Apr 29, 2015 View HTML
0001193125-15-154681.pdf
0001193125-15-154681.rtf
0001193125-15-154681.xls
Apr 26, 2016 View HTML
0001193125-16-555202.pdf
0001193125-16-555202.rtf
0001193125-16-555202.xls

Form 10-K

Filing date View
Mar 28, 2014 View HTML
0001193125-14-121353.pdf
0001193125-14-121353.rtf
0001193125-14-121353.xls
Mar 24, 2015 View HTML
0001193125-15-103253.pdf
0001193125-15-103253.rtf
0001193125-15-103253.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Form 10-Q

Filing date View
May 12, 2014 View HTML
0001193125-14-194852.pdf
0001193125-14-194852.rtf
0001193125-14-194852.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Aug 08, 2014 View HTML
0001193125-14-303146.pdf
0001193125-14-303146.rtf
0001193125-14-303146.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 14, 2014 View HTML
0001193125-14-412231.pdf
0001193125-14-412231.rtf
0001193125-14-412231.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Investor Relations

  • Investors
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Analyst Coverage
  • Contact Us

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
:
Day High:
Day Low:
Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.


© 2021, Flexion Therapeutics, Inc.

781.305.7777

Website Design & Development by Graphic Beans

Terms of Use Sitemap Privacy Policy

Connect with us: LinkedIn-whiteTwitter-whiteGlassdoor-white